How much funding has Axio Biosolutions raised?

Axio Biosolutions has raised $20.2M in total funding, most recently a Series B round.

Who are Axio Biosolutions's investors?

Axio Biosolutions's investors include Accel, TrueScale Capital, Ratan Tata's RNT Capital, Omidyar Network India, IDG Capital, Chiratae Ventures.

When was Axio Biosolutions founded?

Axio Biosolutions was founded in 2008.

Where is Axio Biosolutions headquartered?

Axio Biosolutions is headquartered in Bengaluru, India.

What industry is Axio Biosolutions in?

Axio Biosolutions operates in Healthcare, Manufacturing, Medical Devices.

How many employees does Axio Biosolutions have?

Axio Biosolutions has 51-200 employees.

Axio Biosolutions

Bengaluru, India · Founded 2008 · $20.2M raised

Healthcare

Manufacturing

Medical Devices

Headquarters: Bengaluru
Employees: 51–200
Founded: 2008
Business Model: B2B

Website: axiobio.com
Total Funding: $20.2M
Last Round: $6.0M Series BJul 2021
Rounds: 4

About

Axio Biosolutions is a global medtech company based in Bengaluru, India, specializing in advanced hemostatic wound care solutions powered by proprietary Chitosan Technology. Its flagship products, Axiostat hemostatic gauze and MaxioCel wound dressings, are used by emergency responders, military personnel, and healthcare professionals across 50+ countries. The company has impacted over 1 million lives and equipped 1.3 million frontline heroes.

Summary

Axio Biosolutions is a Healthcare company based in Bengaluru, India, founded in 2008. It has raised $20.2M in total across 4 rounds, most recently a $6.0M Series B round in Jul 2021. Investors include Accel, TrueScale Capital and Ratan Tata's RNT Capital.

LinkedIn X (Twitter)